Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study

Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study

Abstract Background and Objective Abiraterone acetate tablet is an inhibitor of androgen synthesis, primarily for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This study evaluated the bioequivalence and pharmacokinetics of the reference and test formulations of abiratero...

Full description

Bibliographic Details
Main Authors: Zhao-xin Wu, Chen-jing Wang, Ping Shi, Yan-ping Liu, Ting Li, Fei-fei Sun, Yao Fu, Xiao-meng Gao, Ya-ping Ma, Yu Cao
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-04-01
Series:Drugs in R&D
Online Access:https://doi.org/10.1007/s40268-023-00418-6

Internet

https://doi.org/10.1007/s40268-023-00418-6

Similar Items